Two separate community studies of participants free of heart disease showed that lower plasma concentrations of the cardiac hormones, ANP and BNP, are associated with increase in vascular stiffness and reduced metabolic health, whereas the opposite is true of CNP concentrations—lower levels associate with improved cardiometabolic health. This evidence concerns the gene NPPA and heart disorder.